- Home
- MDA vs INDV Comparison
MDA vs INDV Comparison
Compare MDA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$30.72
HOLD
Current Price
$30.54
Company Overview
Basic Information| Metric | MDA | INDV |
|---|---|---|
| Founded | 1969 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | 2026 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MDA | INDV |
|---|---|---|
| Price | $30.72 | $30.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 771.5K | ★ 3.0M |
| Earning Date | 03-04-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $11.74 | N/A |
| Revenue Next Year | $12.60 | N/A |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $23.23 | $8.69 |
| 52 Week High | $33.75 | $38.00 |
Technical Indicators
Market Signals| Indicator | MDA | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 47.42 |
| Support Level | $23.23 | $29.71 |
| Resistance Level | $33.75 | $35.75 |
| Average True Range (ATR) | 2.00 | 1.18 |
| MACD | 0.42 | 0.31 |
| Stochastic Oscillator | 81.21 | 57.87 |
Price Performance
Historical Comparison MDA
INDV
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).